(Press-News.org) Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model. The findings were reported in the Sept. 8 issue of the journal Cell Metabolism.
By studying the surface of healthy, live fat cells in rats, researchers were able to understand the process by which cells take in glucose. Next, they plan to observe the fat cells of people with varying degrees of insulin sensitivity, including insulin resistance–considered a precursor to type 2 diabetes [http://diabetes.niddk.nih.gov]. These observations may help identify the interval when someone becomes at risk for developing diabetes.
"What we're doing here is actually trying to understand how glucose transporter proteins called GLUT4 work in normal, insulin-sensitive cells," said Karin G. Stenkula, Ph.D., a researcher at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and a lead author of the paper. "With an understanding of how these transporters in fat cells respond to insulin, we could detect the differences between an insulin-sensitive cell and an insulin-resistant cell, to learn how the response becomes impaired. We hope to identify when a person becomes pre-diabetic, before they go on to develop diabetes."
Glucose, a simple sugar, provides energy for cell functions. After food is digested, glucose is released into the bloodstream. In response, the pancreas secretes insulin, which directs the muscle and fat cells to take in glucose. Cells obtain energy from glucose or convert it to fat for long-term storage.
Like a key fits into a lock, insulin binds to receptors on the cell's surface, causing GLUT4 molecules to come to the cell's surface. As their name implies, glucose transporter proteins act as vehicles to ferry glucose inside the cell.
To get detailed images of how GLUT4 is transported and moves through the cell membrane, the researchers used high-resolution imaging to observe GLUT4 that had been tagged with a fluorescent dye.
The researchers then observed fat cells suspended in a neutral liquid and later soaked the cells in an insulin solution, to determine the activity of GLUT4 in the absence of insulin and in its presence.
In the neutral liquid, the researchers found that individual molecules of GLUT4 as well as GLUT4 clusters were distributed across the cell membrane in equal numbers. Inside the cell, GLUT4 was contained in balloon-like structures known as vesicles. The vesicles transported GLUT4 to the cell membrane and merged with the membrane, a process known as fusion.
After fusion, the individual molecules of GLUT4 are the first to enter the cell membrane, moving at a continuous but relatively infrequent rate. The researchers termed this process fusion with release.
When exposed to insulin, however, the rate of total GLUT4 entry into the cell membrane peaked, quadrupling within three minutes. The researchers saw a dramatic rise in fusion with release – 60 times more often on cells exposed to insulin than on cells not exposed to insulin.
After exposure to insulin, a complex sequence occurred, with GLUT4 shifting from clusters to individual GLUT4 molecules. Based on the total amount of glucose the cells took in, the researchers deduced that glucose was taken into the cell by individual GLUT4 molecules as well as by clustered GLUT4. The researchers also noted that after four minutes, entry of GLUT4 into the cell membrane started to decrease, dropping to levels observed in the neutral liquid in 10 to 15 minutes.
"The magnitude of this change shows just how important the regulation of this process is for the survival of the cell and for the normal function of the whole body," said Joshua Zimmerberg, Ph.D., M.D., the paper's senior author and director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Program in Physical Biology.
The research team next plans to examine the activity of glucose transporters in human fat cells, Zimmerberg said. "Understanding how insulin prepares the cell for glucose uptake may lead to ideas for stimulating this activity when the cells become resistant to insulin."
###
Stenkula and Samuel W. Cushman, Ph.D., of NIDDK worked with NICHD investigators Vladimir A. Lizunov, Ph.D. and Zimmerberg to complete the research.
The NICHD sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. For more information, visit the Institute's Web site at http://www.nichd.nih.gov/.
The NIDDK conducts and supports research in diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe, and disabling conditions affecting Americans. For more information about NIDDK and its programs, see www.niddk.nih.gov.
The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
END
AMES, Iowa -- A new Iowa State University study has found that corn bred to contain increased levels of beta-carotene is a good source of vitamin A. The discovery gives added support to the promise of biofortified corn being developed through conventional plant breeding as an effective tool to combat vitamin A deficiency in developing countries.
Beta-carotene is converted in the body to vitamin A. The researchers found that the beta-carotene in the corn was converted to vitamin A at a higher rate than what's predicted for corn, and higher than the rate for beta-carotene ...
Scientists from the University of California, San Diego School of Medicine have identified dendritic antigen-presenting cells in zebrafish, opening the possibility that the tiny fish could become a new model for studying the complexities of the human immune system.
The study, reported in the online edition of the Proceedings of the National Academy of Sciences, was headed by David Traver, an associate professor in UCSD's Department of Cellular and Molecular Medicine, with colleagues in UCSD's Division of Biological Sciences and at the Brazilian National Cancer Institute. ...
September 7, 2010 (4 pm ET) – Nevirapine is widely used to help prevent mother-to-child transmission of the HIV virus. In cases where the infants are nonetheless infected with HIV virus at birth, the standard treatment is to use protease inhibitors (PI) to reduce the amount of virus in their bloodstream. A new study involving 195 infants in South Africa found that children who were treated with PI and then switched to nevirapine were more likely to maintain virus below the detection threshold of the test than infants who continued to receive PI. Results of the study are ...
Chemists at the University of California, San Diego, have identified how a protein that accumulates in the brains of people with Alzheimer's disease interferes with the ability of cells to get rid of debris. They also found a natural mechanism by which this protein, amyloid beta, itself may be discarded.
Plaques of amyloid are a hallmark of the ailment, but no one is sure exactly how they contribute to catastrophic loss of memory and cognition.
Scientists have begun to suspect that amyloid disables a structure called a proteasome, which chops up proteins that cells ...
Too much testosterone can be a deal breaker, according to Sauder School of Business researchers at the University of British Columbia. Their paper, to be published in the INFORMS journal Management Science on September 10, shows that young CEOs with more of the steroidal hormone in their system are more likely to initiate, scrap or resist mergers and acquisitions.
The study by Sauder Finance Professors Maurice Levi and Kai Li, and PhD student Feng Zhang, titled "Deal or No Deal: Hormones and the Mergers and Acquisitions Game," shows that testosterone – a hormone associated ...
Fairbanks, Alaska—A University of Alaska Fairbanks fisheries scientist has teamed up with Alaska Power and Telephone to study how a new power-generating turbine affects fish in the Yukon River.
So far, the news looks good for the fish.
"In the brief testing that we have been able to accomplish, we have no indication that the turbine has killed or even injured any fish," said Andrew Seitz, project leader and assistant professor of fisheries.
Alaska Power and Telephone installed the in-stream turbine near Eagle, Alaska this summer. They are testing its effectiveness ...
CHAMPAIGN, Ill. – There's a reason why some sports fans are referred to as "die-hards" – even after they move away, their loyalty to their hometown team endures, according to research by two University of Illinois professors.
Scott Tainsky and Monika Stodolska, professors of recreation, sport and tourism, say new residents of a community maintain an attachment to their old team or former city as a way of asserting their identity after they move.
"People new to a city don't just adopt their new hometown's team as a way to acclimate themselves in a new community," Tainsky ...
CHAMPAIGN, Ill. — A University of Illinois economist says consumers and investors concerned about the specter of deflation looming over an already bleak economic landscape should relax – for the time being, at least.
Although the consumer price index is near zero, J. Fred Giertz says we're unlikely to see a prolonged deflationary period like the slump Japan experienced during its "lost decade" of the 1990s.
"We're close to zero right now, but we're not below zero," said Giertz, an Institute of Government and Public Affairs economist who compiles a monthly barometer ...
PROVIDENCE, R.I. [Brown University] — Most proteins are shapely. But about one-third of them lack a definitive form, at least that scientists can readily observe. These intrinsically disordered proteins (IDPs) perform a host of important biological functions, from muscle contraction to other neuronal actions. Yet despite their importance, "We don't know much about them," said Wolfgang Peti, associate professor of medical science and chemistry. "No one really worried about them."
Now, Peti, joined by researchers at the University of Toronto and at Brookhaven National Laboratory ...
A new study identifies molecules that can be used to selectively reduce generation of the sticky, neuron-damaging plaques that are the hallmark of the Alzheimer's disease (AD) brain. The research, published by Cell Press in the September 9 issue of the journal Neuron, may lead to the development of effective and safe therapeutics for this currently incurable disease.
Previous research has suggested that an alteration in brain levels of amyloid ? proteins (A?) plays a major pathogenic role in AD, a devastating neurodegenerative disorder that causes progressive cognitive ...
